Close Menu

NEW YORK (360Dx) – Scientists at Seattle Children's Hospital are developing mass spectrometry-based protein tests for screening newborns for various immunodeficiency disorders.

The researchers have formed a company, Key Proteo, to support the effort and are planning a large-scale pilot study to evaluate their assays, said Sihoun Hahn, principal investigator at Seattle Children's Research Institute and leader of the effort.

Hahn has received four grants from the National Institute of Allergy and Infectious Diseases totaling $3.7 million in support of the work.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.